NEXPHORIA
Thymosin Alpha-1
Thymic immunomodulatory peptide. T-cell activation and immune balance research.
Purchase Type
Fresh cold-chain delivery every 30 days
For Research Use Only — Not For Human Consumption
This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.
Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide originally isolated from thymosin fraction 5 of bovine thymus tissue by Goldstein and colleagues. It represents the biologically active N-terminal fragment of prothymosin alpha. Tα1 has received regulatory approval in over 35 countries (tradename Zadaxin, SciClone Pharmaceuticals) for hepatitis B, hepatitis C, and as an immune adjuvant in cancer treatment.
Complete Your Protocol
Related compounds.
Side-by-Side Analysis
Compare Thymosin Alpha-1 with Similar Compounds
View purity, MW, storage, and pricing side by side.
Frequently Bought Together
Complete Your Protocol
Researchers commonly order these compounds together. Convenient multi-compound ordering.
Wellness
This itemThymosin Alpha-1
5mg
$66
Wellness
RecommendedLL-37
5mg
$72
Wellness
NAD+
100mg
$30
3 items selected
Uncheck any item to customize your bundle. Discount applied automatically at checkout.
Research Journal
Related Research Articles
Thymosin Alpha-1: The Immune-Modulating Peptide
A comprehensive research review of Thymosin Alpha-1 (Tα1): origin, TLR/T-cell/NK cell immune mechanisms, clinical trial data in HCC, melanoma, HBV/HCV, and COVID-19 cohorts, plus preclinical dosing protocols and research design considerations.
Peptide Research for Autoimmune and Chronic Inflammatory Conditions: KPV, Thymosin Alpha-1, LL-37, and BPC-157
A comprehensive research protocol guide covering KPV, Thymosin Alpha-1, LL-37, and BPC-157 for autoimmune and chronic inflammatory research models. Covers receptor pharmacology, published preclinical and clinical data, multi-compound study design, endpoint selection, and critical controls.
KLW Stack: KPV + LL-37 + Thymosin Alpha-1 Triple Immune Modulation Research Guide
Comprehensive research guide to the KLW triple immune stack covering three orthogonal immune pathways — NF-κB suppression (KPV), innate antimicrobial defense (LL-37), and adaptive T-cell activation (Thymosin Alpha-1). Protocol design, dosing, endpoints, and synergy rationale.
Complete Your Protocol
Immune Research Stack
Thymosin Alpha-1's T-cell modulation pairs with LL-37's innate immune activation for a multi-arm immunomodulatory research protocol.
Wellness
Thymosin Alpha-1
5mg
$66
Wellness
LL-37
5mg
$72